Esperion Therapeutics, Inc. ESPR
3.18 USD 0.00 (+0.00%)
At closeJul 13, 2026, 4:00 PM EDT
3.15 -0.03 -0.94%
After hours · Jul 13, 4:00 PM ET
3.18 Day range 3.18
52-week range unavailable
- YTD
- -14.05%
- 1 year
- +211.76%
ESPR revenue history
Revenue is income from the company’s ordinary business activities.
403,135,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 403,135,000 | 70,821,000 | 21.31% |
| FY 2024 | 2024-12-31 | 332,314,000 | 215,980,000 | 185.66% |
| FY 2023 | 2023-12-31 | 116,334,000 | 40,859,000 | 54.14% |
| FY 2022 | 2022-12-31 | 75,475,000 | -2,972,000 | -3.79% |
| FY 2021 | 2021-12-31 | 78,447,000 | -149,100,000 | -65.52% |
| FY 2020 | 2020-12-31 | 227,547,000 | 79,183,000 | 53.37% |
| FY 2019 | 2019-12-31 | 148,364,000 | 148,364,000 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | 0 | Not meaningful |
| FY 2012 | 2012-12-31 | 0 | 0 | Not meaningful |
| FY 2011 | 2011-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:43:43.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.